Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 11.43
-0.02 (-0.17%)
Sep 24, 2026, 10:05 AM EST
Eupraxia Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Eupraxia Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $16.00. The average 1-year stock price forecast is 39.98% higher than the current stock price, while the lowest is $14.00 (+22.48%) and the highest is $18.00 (+57.48%).
Price Target: $16.00 (+39.98%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eupraxia Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 11 | 11 | 11 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $23.99 | Buy | Initiates | $23.99 | +109.86% | Sep 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $35.27 | Buy | Reiterates | $35.27 | +208.61% | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $15.52 | Buy | Maintains | $15.52 | +35.79% | Sep 22, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 27, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.58 | Buy | Maintains | $22.58 | +97.51% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
548.77K
EPS This Year
-0.96
from -1.00
EPS Next Year
-1.03
from -0.96
EPS and Forward PE are based on non-GAAP adjusted numbers.